Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain comprises five major protein complexes (I-V), embedded in the inner membrane, that work together to oxidize electron donors (NADH, FADH2), transport electrons through a series of redox reactions, pump protons to create an electrochemical gradient, and synthesize ATP from ADP and inorganic phosphate via ATP synthase (complex V). Complexes I-IV transfer electrons and pump protons, while complex V uses the proton gradient to drive ATP synthesis. Dysfunction or inhibition of these complexes can result in severe metabolic and degenerative diseases, and they are targets for several drugs and toxins.
Inhibition of electron transfer Disruption of proton gradient (uncoupling) Inhibition of ATP synthesis Generation of reactive oxygen species (ROS)
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain complex I, II, III, IV, and V proteins (ETC complexes I-V (or Complex I, II, III, IV, V)).